New 15% tariffs face legal challenges; trade uncertainty looms. Experts cite obsolete law.
Prediction markets like Kalshi & Polymarket face scrutiny. Traders lost thousands; integrity's at risk.
Bourbon's world-class win under $50! High returns, low valuation, and accessible risk for spirits investors.
Novocure's stock jumps 37% on FDA approval for its pancreatic cancer device. High hopes for patient returns.
Microsoft's $1B OpenAI bet now worth $135B, yielding $7.6B net income. High risk, high reward!
GOOGL's 745% 10-yr return shines despite AI selloff. Strong cash flow & 16.6% revenue growth outlook at 22x forward earnings.
Bitcoin plunges 40%, losing its 'digital gold' narrative. Gold & stablecoins now win macro & payments.